Two highly publicized fundraisers based in the UK have drawn attention to an unusual practice by the Burzynski Research Institute Inc. in Houston, triggering a storm of criticism in the blogosphere. The institute charges exhorbitant fees to patients for participation in its many ongoing trials of its investigative antineoplaston cancer therapy, even though there are no randomized, controlled trials proving the effectiveness of the therapy in the peer-reviewed scientific literature.